Can Moderna Meet Its COVID Vaccine Expectations?
Non-Profit Competition Will Hit Revenues
Analysts have cut forecasts for Moderna’s COVID-19 vaccine – but there is still much to play for as key readouts approach.
Analysts have cut forecasts for Moderna’s COVID-19 vaccine – but there is still much to play for as key readouts approach.